105 related articles for article (PubMed ID: 17196996)
1. Gaboxadol, a selective extrasynaptic GABA(A) agonist, does not generalise to other sleep-enhancing drugs: a rat drug discrimination study.
McDonald LM; Sheppard WF; Staveley SM; Sohal B; Tattersall FD; Hutson PH
Neuropharmacology; 2007 Mar; 52(3):844-53. PubMed ID: 17196996
[TBL] [Abstract][Full Text] [Related]
2. Gaboxadol -- a different hypnotic profile with no tolerance to sleep EEG and sedative effects after repeated daily dosing.
Ebert B; Anderson NJ; Cremers TI; Rasmussen S; Vogel V; Fahey JM; Sánchez C
Pharmacol Biochem Behav; 2008 Jul; 90(1):113-22. PubMed ID: 18304623
[TBL] [Abstract][Full Text] [Related]
3. Discriminative stimulus effects of tiagabine and related GABAergic drugs in rats.
McDonald LM; Sheppard WF; Staveley SM; Sohal B; Tattersall FD; Hutson PH
Psychopharmacology (Berl); 2008 May; 197(4):591-600. PubMed ID: 18264695
[TBL] [Abstract][Full Text] [Related]
4. Comparative cue generalization profiles of L-838, 417, SL651498, zolpidem, CL218,872, ocinaplon, bretazenil, zopiclone, and various benzodiazepines in chlordiazepoxide and zolpidem drug discrimination.
Mirza NR; Rodgers RJ; Mathiasen LS
J Pharmacol Exp Ther; 2006 Mar; 316(3):1291-9. PubMed ID: 16339395
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of the selective extrasynaptic GABA A agonist, gaboxadol, in a model of transient insomnia: a randomized, controlled clinical trial.
Walsh JK; Mayleben D; Guico-Pabia C; Vandormael K; Martinez R; Deacon S
Sleep Med; 2008 May; 9(4):393-402. PubMed ID: 17765013
[TBL] [Abstract][Full Text] [Related]
6. Lack of generalisation between the GABAA receptor agonist, gaboxadol, and allosteric modulators of the benzodiazepine binding site in the rat drug discrimination procedure.
Michelsen S; Sánchez C; Ebert B
Psychopharmacology (Berl); 2007 Jul; 193(1):151-7. PubMed ID: 17361395
[TBL] [Abstract][Full Text] [Related]
7. Centrally-mediated antinociceptive actions of GABA(A) receptor agonists in the rat spared nerve injury model of neuropathic pain.
Rode F; Jensen DG; Blackburn-Munro G; Bjerrum OJ
Eur J Pharmacol; 2005 Jun; 516(2):131-8. PubMed ID: 15936014
[TBL] [Abstract][Full Text] [Related]
8. Gaboxadol--a new awakening in sleep.
Wafford KA; Ebert B
Curr Opin Pharmacol; 2006 Feb; 6(1):30-6. PubMed ID: 16368265
[TBL] [Abstract][Full Text] [Related]
9. [New hypnotics: perspectives from sleep physiology].
Jufe GS
Vertex; 2007; 18(74):294-9. PubMed ID: 18265473
[TBL] [Abstract][Full Text] [Related]
10. The EEG effects of THIP (Gaboxadol) on sleep and waking are mediated by the GABA(A)delta-subunit-containing receptors.
Winsky-Sommerer R; Vyazovskiy VV; Homanics GE; Tobler I
Eur J Neurosci; 2007 Mar; 25(6):1893-9. PubMed ID: 17408425
[TBL] [Abstract][Full Text] [Related]
11. The GABA(A) agonist gaboxadol improves the quality of post-nap sleep.
Mathias S; Steiger A; Lancel M
Psychopharmacology (Berl); 2001 Sep; 157(3):299-304. PubMed ID: 11605086
[TBL] [Abstract][Full Text] [Related]
12. Discriminative stimulus effects of zolpidem in squirrel monkeys: role of GABA(A)/alpha1 receptors.
Rowlett JK; Spealman RD; Lelas S; Cook JM; Yin W
Psychopharmacology (Berl); 2003 Jan; 165(3):209-15. PubMed ID: 12420154
[TBL] [Abstract][Full Text] [Related]
13. The selective extrasynaptic GABAA agonist, gaboxadol, improves traditional hypnotic efficacy measures and enhances slow wave activity in a model of transient insomnia.
Walsh JK; Deacon S; Dijk DJ; Lundahl J
Sleep; 2007 May; 30(5):593-602. PubMed ID: 17552374
[TBL] [Abstract][Full Text] [Related]
14. GABA(A) agonists and partial agonists: THIP (Gaboxadol) as a non-opioid analgesic and a novel type of hypnotic.
Krogsgaard-Larsen P; Frølund B; Liljefors T; Ebert B
Biochem Pharmacol; 2004 Oct; 68(8):1573-80. PubMed ID: 15451401
[TBL] [Abstract][Full Text] [Related]
15. Selective GABA transporter inhibitors tiagabine and EF1502 exhibit mechanistic differences in their ability to modulate the ataxia and anticonvulsant action of the extrasynaptic GABA(A) receptor agonist gaboxadol.
Madsen KK; Ebert B; Clausen RP; Krogsgaard-Larsen P; Schousboe A; White HS
J Pharmacol Exp Ther; 2011 Jul; 338(1):214-9. PubMed ID: 21450931
[TBL] [Abstract][Full Text] [Related]
16. Modulation of extrasynaptic THIP conductances by GABAA-receptor modulators in mouse neocortex.
Drasbek KR; Hoestgaard-Jensen K; Jensen K
J Neurophysiol; 2007 Mar; 97(3):2293-300. PubMed ID: 17215511
[TBL] [Abstract][Full Text] [Related]
17. Differences between magnetoencephalographic (MEG) spectral profiles of drugs acting on GABA at synaptic and extrasynaptic sites: a study in healthy volunteers.
Nutt D; Wilson S; Lingford-Hughes A; Myers J; Papadopoulos A; Muthukumaraswamy S
Neuropharmacology; 2015 Jan; 88():155-63. PubMed ID: 25195191
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of sleep induction by GABA(A) receptor agonists.
Harrison NL
J Clin Psychiatry; 2007; 68 Suppl 5():6-12. PubMed ID: 17539703
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological characterization of agonists at delta-containing GABAA receptors: Functional selectivity for extrasynaptic receptors is dependent on the absence of gamma2.
Stórustovu SI; Ebert B
J Pharmacol Exp Ther; 2006 Mar; 316(3):1351-9. PubMed ID: 16272218
[TBL] [Abstract][Full Text] [Related]
20. Extrasynaptic GABAA receptors in rat pontine reticular formation increase wakefulness.
Vanini G; Baghdoyan HA
Sleep; 2013 Mar; 36(3):337-43. PubMed ID: 23450652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]